NCT00239876

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

A Two-year Extension to a One-year, Multicenter, Open-label, Randomised Study to Evaluate the Safety and Efficacy of FTY720 Combined With Tacrolimus and Steroids Versus Mycophenolate Mofetyl Combined With Tacrolimus and Steroids, in de Novo Adult Renal Transplant Recipients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 140 (planned)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: —

Summary

This study will evaluate the safety and efficacy of FTY720 combined with tacrolimus and corticosteroids in patients receiving a kidney transplant

Conditions

• Renal Transplantation

Interventions

Type	Name	Description
DRUG	FTY720

Timeline

• Start date: 2005-05-01
• Primary completion: 2005-12-01
• First posted: 2005-10-17
• Last updated: 2011-11-02